Update on Adjuvant Trials for Pancreatic Cancer

Surgical Oncology Clinics of North America

Volumn 19, Issue 2, 2010, Pages 391-409

  Backlund, Dana C ^a   Berlin, Jordan D ^a   Parikh, Alexander A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Chemoradiation; Management; Neoadjuvant; Pancreatic cancer

Indexed keywords

FLUOROURACIL; GEMCITABINE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DRUG EFFICACY; FEASIBILITY STUDY; HUMAN; MONOTHERAPY; PANCREAS CANCER; PANCREAS RESECTION; PATIENT CARE; PATIENT SAFETY; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); RADIATION SAFETY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 75849136627     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.11.003     Document Type: Review

References (53)

1. Jemal A., Siegel R., and Ward E. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Golcher H., Brunner T., Grabenbauer G., et al. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol 34 7 (2008) 756-764
3. Kim H.J., Czischke K., Brennan M.F., et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg 6 5 (2002) 763-769
4. Tse R.V., Dawson L.A., Wei A., et al. Neoadjuvant treatment for pancreatic cancer-a review. Crit Rev Oncol Hematol 65 3 (2008) 263-274
5. Greer S.E., Pipas J.M., Sutton J.E., et al. Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma. J Am Coll Surg 206 3 (2008) 451-457
6. Katz M.H., Wang H., Fleming J.B., et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16 4 (2009) 836-847
7. Lowy A.M. Neoadjuvant therapy for pancreatic cancer. J Gastrointest Surg 12 9 (2008) 1600-1608
8. Kaiser M.H., and Ellenberg S.S. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 8 (1985) 899-903
9. Klinkenbijl J.H., Jeekel J., Sahmoud T., et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230 6 (1999) 776-782 [discussion: 782-74]
10. Neoptolemos J.P., Kerr D.J., Beger H., et al. ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion 58 6 (1997) 570-577
11. Neoptolemos J.P., Dunn J.A., Stocken D.D., et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358 9293 (2001) 1576-1585
12. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 12 (2004) 1200-1210
13. Neoptolemos J.P., Stocken D.D., Tudur Smith C., et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 100 2 (2009) 246-250
14. Oettle H., Post S., Neuhaus P., et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297 3 (2007) 267-277
15. Neuhaus P., Riess H., Post S., et al. Deutsche krebsgesellschaft. CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). [abstract]. J Clin Oncol 26 Suppl (2008) 4504
16. Regine W.F., Winter K.A., Abrams R.A., et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299 9 (2008) 1019-1026
17. Neoptolemos J., Buchler M., Stocken D., et al. ESPAC-3(v2): a multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. [abstract]. Proc Am Soc Clin Oncol 27 18 Suppl (2009) 4505
18. VanLaethem J.L., Mornex F., Azria D., et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiation after curative resection for pancreatic cancer: updated results of a randomized EORTC/FFCD/GERCOR phase II study (40013-22012/9203). [abstract 4527]. Proc Am Soc Clin Oncol (2009)
19. Cheng T.Y., Sheth K., White R.R., et al. Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol 13 1 (2006) 66-74
20. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 5 (1997) 632-641
21. Spitz F.R., Abbruzzese J.L., Lee J.E., et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15 3 (1997) 928-937
22. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 3 (2002) 355-366 [discussion: 366-58]
23. Hodul P., Creech S., Pickleman J., et al. The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy. Am J Surg 186 5 (2003) 420-425
24. Hoffman J.P., Lipsitz S., Pisansky T., et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 16 1 (1998) 317-323
25. Povoski S.P., Karpeh Jr. M.S., Conlon K.C., et al. Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg 3 5 (1999) 496-505
26. Povoski S.P., Karpeh Jr. M.S., Conlon K.C., et al. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230 2 (1999) 131-142
27. Sohn T.A., Yeo C.J., Cameron J.L., et al. Do preoperative biliary stents increase postpancreaticoduodenectomy complications?. J Gastrointest Surg 4 3 (2000) 258-267 [discussion: 267-58]
28. Velanovich V., Kheibek T., and Khan M. Relationship of postoperative complications from preoperative biliary stents after pancreaticoduodenectomy. A new cohort analysis and meta-analysis of modern studies. JOP 10 1 (2009) 24-29
29. Raut C.P., Grau A.M., Staerkel G.A., et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7 1 (2003) 118-126 [discussion: 118-27]
30. Evans D.B., Rich T.A., Byrd D.R., et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127 11 (1992) 1335-1339
31. Pisters P.W., Abbruzzese J.L., Janjan N.A., et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 16 12 (1998) 3843-3850
32. Yeung R.S., Weese J.L., Hoffman J.P., et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer 72 7 (1993) 2124-2133
33. Moutardier V., Magnin V., Turrini O., et al. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 60 2 (2004) 437-443
34. Mornex F., Girard N., Delpero J.R., et al. Radiochemotherapy in the management of pancreatic cancer-part I: neoadjuvant treatment. Semin Radiat Oncol 15 4 (2005) 226-234
35. Talamonti M.S., Small Jr. W., Mulcahy M.F., et al. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 13 2 (2006) 150-158
36. Evans D.B., Varadhachary G.R., Crane C.H., et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26 21 (2008) 3496-3502
37. Varadhachary G.R., Wolff R.A., Crane C.H., et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26 21 (2008) 3487-3495
38. Callery M.P., Chang K.J., Fishman E.K., et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16 7 (2009) 1727-1733
39. Allendorf J.D., Lauerman M., Bill A., et al. Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. J Gastrointest Surg 12 1 (2008) 91-100
40. Ammori J.B., Colletti L.M., Zalupski M.M., et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 7 6 (2003) 766-772
41. Pipas J.M., Barth Jr. R.J., Zaki B., et al. Docetaxel/gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma. Ann Surg Oncol 12 12 (2005) 995-1004
42. Massucco P., Capussotti L., Magnino A., et al. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol 13 9 (2006) 1201-1208
43. Brunner T.B., Grabenbauer G.G., Meyer T., et al. Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO). BMC Cancer 7 (2007) 41
44. Staley C.A., Lee J.E., Cleary K.R., et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171 1 (1996) 118-124 [discussion: 115-24]
45. Pisters P.W., Wolff R.A., Janjan N.A., et al. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol 20 10 (2002) 2537-2544
46. White R.R., and Tyler D.S. Neoadjuvant therapy for pancreatic cancer: the Duke experience. Surg Oncol Clin N Am 13 4 (2004) 675-684 ix-x
47. Palmer D.H., Stocken D.D., Hewitt H., et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 14 7 (2007) 2088-2096
48. Kamthan A.G., Morris J.C., Dalton J., et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 15 8 (1997) 2920-2927
49. Snady H., Bruckner H., Cooperman A., et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 89 2 (2000) 314-327
50. Aristu J., Canon R., Pardo F., et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 26 1 (2003) 30-36
51. Joensuu T.K., Kiviluoto T., Karkkainen P., et al. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 60 2 (2004) 444-452
52. Isacoff W.H., Bendetti J.K., Barstis J.J., et al. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. J Clin Oncol 25 13 (2007) 1665-1669
53. Small W., Berlin J., Freedman G., et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol 26 6 (2008) 942-947